» Articles » PMID: 36588938

Hyaluronic Acid Ameliorates Intervertebral Disc Degeneration Promoting Mitophagy Activation

Overview
Date 2023 Jan 2
PMID 36588938
Authors
Affiliations
Soon will be listed here.
Abstract

Activation of mitophagy was considered to be a potential therapeutic strategy for intervertebral disc degeneration (IDD). There was evidence suggesting that hyaluronic acid (HA) can protect mitochondria from oxidative stress in chondrocytes, but its protective effects and mechanism in nucleus pulposus cells (NPCs) remain unclear. This study aimed to confirm the effect of HA promoting mitophagy and protecting mitochondria function in NPCs, and explore its underlying mechanism. NPCs were treated with high molecular weight HA, tert-butyl hydroperoxide (TBHP) and Cyclosporin A (CsA). Mitophagy, mitochondrial function, apoptosis, senescence and extracellular matrix (ECM) degradation were measured. Then, NPCs were transfected with C1QBP siRNA, mitophagy and mitochondrial function were tested. The therapeutic effects of HA on IDD by promoting mitophagy were assessed in bovine intervertebral disc organ culture model. The results showed that TBHP induced oxidative stress, mitochondrial dysfunction, NPCs apoptosis, senescence and ECM degradation. Treated by HA, mitophagy was activated, concomitantly, mitochondrial dysfunction, apoptosis, senescence and ECM degradation were ameliorated. Mitophagy inhibition by CsA partially eliminated the protective effects of HA against oxidative stress. After transfected with C1QBP siRNA to reduce the expression of C1QBP in NPCs, the effect of HA promoting mitophagy was inhibited and the protective effect of HA against oxidative stress was weaken. Additionally, HA alleviated NPCs apoptosis and ECM degradation in bovine intervertebral disc organ culture model. These findings suggest that HA can protect mitochondrial function through activation of mitophagy in NPCs and ameliorate IDD. Furthermore, C1QBP is involved in HA promoting mitophagy and protecting NPCs from oxidative stress. Taken together, our results provide substantial evidence for the clinical applications of HA in the prevention and treatment of IDD.

Citing Articles

Polysaccharide-based biomaterials for regenerative therapy in intervertebral disc degeneration.

Wang X, Huang Y, Yang Y, Tian X, Jin Y, Jiang W Mater Today Bio. 2025; 30:101395.

PMID: 39759846 PMC: 11699348. DOI: 10.1016/j.mtbio.2024.101395.


Role of oxidative stress in mitochondrial dysfunction and their implications in intervertebral disc degeneration: Mechanisms and therapeutic strategies.

Zhou H, Wu C, Jin Y, Wu O, Chen L, Guo Z J Orthop Translat. 2024; 49:181-206.

PMID: 39483126 PMC: 11526088. DOI: 10.1016/j.jot.2024.08.016.


Machine learning and single-cell analysis identify the mitophagy-associated gene TOMM22 as a potential diagnostic biomarker for intervertebral disc degeneration.

Wu Y, Wu S, Chen Z, Yang E, Yu H, Zhang G Heliyon. 2024; 10(17):e37378.

PMID: 39296040 PMC: 11407931. DOI: 10.1016/j.heliyon.2024.e37378.


Orthobiologic Management Options for Degenerative Disc Disease.

de Oliveira C, Oliveira B, Theodoro R, Wang J, Santos G, Rodrigues B Bioengineering (Basel). 2024; 11(6).

PMID: 38927827 PMC: 11200769. DOI: 10.3390/bioengineering11060591.

References
1.
Ni H, Williams J, Ding W . Mitochondrial dynamics and mitochondrial quality control. Redox Biol. 2014; 4:6-13. PMC: 4309858. DOI: 10.1016/j.redox.2014.11.006. View

2.
Ghebrehiwet B, Geisbrecht B, Xu X, Savitt A, Peerschke E . The C1q Receptors: Focus on gC1qR/p33 (C1qBP, p32, HABP-1). Semin Immunol. 2019; 45:101338. DOI: 10.1016/j.smim.2019.101338. View

3.
Wang F, Cai F, Shi R, Wang X, Wu X . Aging and age related stresses: a senescence mechanism of intervertebral disc degeneration. Osteoarthritis Cartilage. 2015; 24(3):398-408. DOI: 10.1016/j.joca.2015.09.019. View

4.
Zhang F, Liu X, Li B, Li Z, Grad S, Chen D . The effect of hyaluronic acid on nucleus pulposus extracellular matrix production through hypoxia-inducible factor-1α transcriptional activation of CD44 under hypoxia. Eur Cell Mater. 2021; 41:142-152. DOI: 10.22203/eCM.v041a10. View

5.
Kang L, Liu S, Li J, Tian Y, Xue Y, Liu X . The mitochondria-targeted anti-oxidant MitoQ protects against intervertebral disc degeneration by ameliorating mitochondrial dysfunction and redox imbalance. Cell Prolif. 2020; 53(3):e12779. PMC: 7106957. DOI: 10.1111/cpr.12779. View